Health & Personal Care
HIGH
FDA DRUG
Harbin Jixianglong Biotech Semaglutide Rx Compounding Recall (2026)
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Harbin Jixianglong Biotech Co.
CGMP Deviations